CARDIOVASCULAR JOURNAL OF AFRICA • Volume 30, No 2, March/April 2019
86
AFRICA
30. Yan J, Zhao W, Thomson JK, Gao X, DeMarco DM, Carrillo E,
et al
.
Stress signaling JNK2 crosstalk with CaMKII underlies enhanced atrial
arrhythmogenesis.
Circ Res
2018; 16
;
122
(6): 821
–
835.
31. Davis RJ. Signal transduction by the JNK group of map kinases.
Cell
2000;
103
: 239
–
252
32. Yan J, Thomson JK, Zhao W, Wu X, Gao X, DeMarco D,
et al
. The
stress kinase JNK regulates gap junction Cx43 gene expression and
promotes atrial fibrillation in the aged heart.
J Mol Cell Cardiol
2017;
11
4: 105
–
115.
33. Yan J, Thomson JK, Zhao W, Gao X, Huang F, Chen B,
et al
. Role of
stress kinase JNK in binge alcohol-evoked atrial arrhythmia.
J Am Coll
Cardiol
2018;
71
(13): 1459
–
1470.
speaking with one voice, will eventually benefit the many.
As laudable as it is to have the highest standards of modern
valve repair in mind when bringing help to low-income countries,
it will continue to exclude the many from life-saving operations.
Local capacity building on the basis of simple, life-saving
replacement-valve surgery has worked before and went hand
in hand with the transition of a country from low to middle
income. Once this feasibility is established, as the examples of
Alain Carpentier’s centre in Saigon and Magdi Yacoub’s in
Aswan, Egypt, have demonstrated, advanced valve repair and
paediatric cardiac surgery can eventually blossom.
4
Cape Town plays more than a symbolic role in this initiative.
It is the home not solely of the only dedicated public paediatric
cardiac centre on the African continent that exclusively caters for
indigent patients, but also to an international nucleus for rheumatic
heart disease research, previously under the leadership of Bongani
Mayosi. Together with the World Heart Federation in Geneva, one
of CSIA’s founding members, this scientific embedding guides the
intersociety initiative on the basis of factual insight.
In this regard, the REMEDY study under the co-ordination
of Zühlke and the late Mayosi highlighted the frightening
percentage of rheumatic patients in need of double-valve
surgery.
5
Are Kinsley
et al
. proposing to send super-specialised
teams performing a combination of Ozaki or Ross procedures
with a complex mitral repair, as spearheaded by Taweesak
Chotivatanapong, in 56 to 58% of patients between 21 and 40
years of age who would need surgery for both the aortic and
mitral valve? Or are they proposing to establish ‘regional cardiac
hubs’ with this level of skills from the beginning? If not, it is
difficult to see where they take issue with the CSIA.
Kinsley
et al
. seem to be of the opinion that valve-replacement
surgery is catastrophic and therefore patients not lucky enough
to reach a ‘private–public’ partnership regional centre with its
world-class experts should rather be left to die. Based on our own
research, we concur with the authors that the implantation of
mechanical valves is far from an ideal solution.
6
Nonetheless, in
the neglected regions of the world, where any cardiac operation
is vanishingly rare and re-operations totally unavailable, these
operations have proven life-saving and life-extending to many
patients in very austere conditions.
Those of us working in tertiary institutions, which primarily treat
indigent patients with rheumatic heart disease, have long pushed
the boundaries towards suitable replacement valves, irrespective of
the undisputed benefit of repairs over replacements.
7,8
Connecting
all these dots as they appear on the radar screens of all, and striving
to identify and promote best practices and uniform standards of
care are among the goals of CSIA.
The CSIA is an umbrella organisation that, together with the
World Heart Federation, strives to bring structured, transparent
support and oversight to local capacity building in cardiac
surgery in low-income countries. It will be a long and challenging
journey, but the global community of professional bodies
representing both the pioneer spirit and the idealistic side of our
discipline believes that such an approach will eventually help
more indigent patients to receive life-saving heart surgery and
acknowledge the dignity of emerging modern societies in the
underprivileged regions of the world in lieu of perpetuating a
paternalistic model that helps only a few.
Although Kinsley
et al
. seem to be critical of the goals of the
CSIA, they actually confirm most of its goals.
University of Cape Town, South Africa
Peter Zilla, MD, PhD
University of Colorado, USA
R Morton Bolman III, MD
References
1.
Sliwa K, Zilla P. Rheumatic heart disease. The tip of the iceberg.
Circulation
2012;
125
: 3060–3062.
2.
Zilla P, Yacoub M, Zühlke L, Beyersdorf F, Sliwa K, Khubulava G,
et al.
Global unmet needs in cardiac surgery.
Global Heart
2018;
13
: 293–303.
3.
Zilla P, Bolman RM, Yacoub MH, Beyersdorf F, Sliwa K, Zühlke L,
et al
. The Cape Town Declaration on Access to Cardiac Surgery in the
Developing World.
Cardiovasc J Afr
2018;
29
: 256–259;
J Thorac Cardiovasc
Surg
2018;
156
: 2206–2209;
Ann Thorac Surg
2018;
106
: 930–933;
Eur J
Cardiothorac Surg
2018;
54
: 407–410;
SA Med J
2018;
108
: 702–704;
SA
Heart J
2018;
15
: 190–194;
Asian Cardiovasc Thorac Ann
2018;
26
: 535–539.
4.
Yacoub M, Elguindy A, Afifi A, Yacoub L, Wright G. Taking cardiac
surgery to the people.
J Cardiovasc Trans Res
204;
7
: 797–802.
5.
Zuhlke L, Engel ME, Karthikeyan G, Rangarajan S, Mackie P, Cupido
B,
et al.
Characteristics, complications, and gaps in evidence-based inter-
ventions in rheumatic heart disease: the Global Rheumatic Heart Disease
Registry (the REMEDY study).
Eur Heart J
2015;
36
: 1115–1122.
6.
Scherman J, Manganyi R, Human P, Pennel T, Brooks A, Brink J, Zilla
P.
Isolated mechanical aortic valve replacement in rheumatic patients in
a low- to middle-income country.
J Thorac Cardiovasc Surg
2018: 1–8.
7.
Scherman J, Appa H, Heerden C, Ofoegbu C, Bezuidenhout D, Zilla P.
Transcatheter valve with a hollow balloon for aortic valve insufficiency.
Multimedia manual of cardiothoracic surgery: MMCTS 2018.
8.
Bezuidenhout D, Williams DF, Zilla P. Polymeric heart valves for surgi-
cal implantation, catheter-based technologies and heart assist devices.
Biomaterials
2015;
36
: 6–25.
…continued from page 74